Moors & Cabot, Inc.

SEC CIK: 0001607239
Latest filing: Aug 10, 2026

SEC filings (opens in a new tab)

MBRX holding history

Moleculin Biotech, Inc. in every 13F filed by Moors & Cabot, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MBRX overview All 13F holders of MBRX Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q3 2025

Holdings of MBRX by Moors & Cabot, Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−400−100.0%	Sold outConverted for a 1-for-25 split	Holders
Q3 2025	10,000	$5.30K	<0.1%	+10,000	New	Holders